ROS signalling between endothelial cells and cardiac cells

Cardiovascular Research

Volumn 102, Issue 2, 2014, Pages 249-257

  Zhang, Min ^a   Shah, Ajay M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiomyocyte; Endothelial cell; NADPH oxidase; Nitric oxide; Paracrine; Redox signalling

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ANGIOGENESIS; CELL COMMUNICATION; CELL GROWTH; CELL TYPE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FIBROBLAST; HEART CONTRACTION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

ANIMALS; ENDOTHELIAL CELLS; FIBROBLASTS; HUMANS; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84899126216     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu050     Document Type: Review

References (143)

1. Tirziu D Giordano FJ Simons M. Cell communications in the heart. Circulation 2010; 122:928-937
2. Tian Y Morrisey EE. Importance of myocyte-nonmyocyte interactions in cardiac development and disease. Circ Res 2012;110:1023-1034
3. Hudlicka O Brown M Egginton S. Angiogenesis in skeletal and cardiac muscle. Physiol Rev 1992;72:369-417
4. Shah AM. Paracrine modulation of heart cell function by endothelial cells. Cardiovasc Res 1996;31:847-867
5. Hsieh PCH Davis ME Lisowski LK Lee RT. Endothelial-cardiomyocyte interactions in cardiac development and repair. Annu Rev Physiol 2006;68:51-66
6. Brutsaert DL Fransen P Andries LJ De KeulenaerGW Sys SU. Cardiac endothelium and myocardial function. Cardiovasc Res 1998;38:281-290
7. Brutsaert DL Meulemans AL Sipido KR Sys SU. Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle. Circ Res 1988;62: 358-366
8. Li K Rouleau JL Andries LJ Brutsaert DL. Effect of dysfunctional vascular endothelium on myocardial performance in isolated papillary muscles. Circ Res 1993;72:768-777
9. Paulus WJ Vantrimpont PJ Shah AM. Paracrine coronary endothelial control of left ventricular function in humans. Circulation 1995;92:2119-2126
10. Smith JA Shah AM Lewis MJ. Factors released from endocardium of the ferret and pig modulate myocardial contraction. J Physiol 1991;439:1-14
11. Brutsaert DL. Cardiac endothelial-myocardial signaling: Its role in cardiac growth contractile performance and rhythmicity. Physiol Rev 2003;83:59-115
12. Seddon M Shah AM Casadei B. Cardiomyocytes as effectors of nitric oxide signalling. Cardiovasc Res 2007;75:315-326
13. Shah AM Spurgeon HA Sollott SJ Talo A Lakatta EG. 8-bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes. Circ Res 1994;74:970-978
14. Paulus WJ Vantrimpont PJ Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation 1994;89:2070-2078
15. Layland J Li JM Shah AM. Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. J Physiol 2002;540: 457-467
16. Cleaver O Melton DA. Endothelial signaling during development. Nat Med 2003;9: 661-668
17. Burgoyne JR Mongue-Din H Eaton P Shah AM. Redox signaling in cardiac physiology and pathology. Circ Res 2012;111:1091-1106
18. HafstadA Nabeebaccus A Shah A.Novel aspects ofROSsignalling in heart failure. Basic Res Cardiol 2013;108:1-11
19. Santos CXC Anilkumar N Zhang M Brewer AC Shah AM. Redox signaling in cardiac myocytes. Free Radic Biol Med 2011;50:777-793
20. Alom-Ruiz SP Anilkumar N Shah AM. Reactive oxygen species and endothelial activation. Antioxid Redox Signal 2008;10:1089-1100
21. Murdoch CE Chaubey S Zeng L Yu B Ivetic AWalker SJ Vanhoutte D Heymans S Grieve DJ Cave AC Brewer AC Zhang M Shah AM. Endothelial NADPH oxidase-2 promotes interstitial cardiac fibrosis and diastolic dysfunction through pro-inflammatory effects and endothelial-mesenchymal transition. J Am Coll Cardiol March 2014; epub ahead of print
22. Zhang M BrewerAC Schroder K SantosCXCGrieve DJWang M Anilkumar N Yu B Dong X Walker SJ Brandes RP Shah AM. NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci USA 2010;107:18121-6
23. Pacher P Beckman JS Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315-424
24. Giordano FJ. Oxygen oxidative stress hypoxia and heart failure. J Clin Invest 2005;115: 500-508
25. Tsutsui H Kinugawa S Matsushima S. Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc Res 2009;81:449-456
26. Nishino T Okamoto K Eger BT Pai EF Nishino T. Mammalian xanthine oxidoreductase- mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J 2008;275:3278-3289
27. Carnicer R Crabtree MJ Sivakumaran V Casadei B Kass DA. Nitric oxide synthases in heart failure. Antioxid Redox Signal 2013;18:1078-1099
28. Zhang M Perino A Ghigo A Hirsch E Shah AM.NADPHoxidases in heart failure: Poachers or gamekeepers?. Antioxid Redox Signal 2013;18:1024-1041
29. ZhangY Tocchetti CG KriegTMoens AL. Oxidative and nitrosative stress in the maintenance of myocardial function. Free Radic Biol Med 2012;53:1531-1540
30. Nediani C Raimondi L Borchi E Cerbai E. Nitric oxide/reactive oxygen species generation and nitroso/redox imbalance in heart failure: From molecular mechanisms to therapeutic implications. Antioxid Redox Signal 2011;14:289-331
31. Brandes RP Weissmann N Schroder K. NADPH oxidases in cardiovascular disease. Free Radic Biol Med 2010;49:687-706
32. Lassegue B San Martin A Griendling KK. Biochemistry physiology and pathophysiology ofNADPHoxidases in the cardiovascular system. Circ Res 2012;110:1364-1390
33. Lambeth JD. Nox enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004;4: 181-189
34. Brown DI Griendling KK. Nox proteins in signal transduction. Free Radic Biol Med 2009; 47:1239-1253
35. Takac I Schroder K Zhang L Lardy B Anilkumar N Lambeth JD Shah AM Morel F Brandes RP. The e-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J Biol Chem 2011;286:13304-13313
36. McNally JS Davis ME GiddensDP Saha A Hwang J Dikalov S Jo H Harrison DG. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol 2003;285: H2290-H2297
37. Hawkins BJ Madesh M Kirkpatrick CJ Fisher AB. Superoxide flux in endothelial cells via the chloride channel-3 mediates intracellular signaling. Mol Biol Cell 2007;18: 2002-2012
38. Doughan AK Harrison DG Dikalov SI. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction. Circ Res 2008;102:488-496
39. Zinkevich NS Gutterman DD. ROS-induced ROS release in vascular biology: Redoxredox signaling. Am J Physiol Heart Circul Physiol 2011;301:H647-H653
40. Dikalov SI Nazarewicz RR Bikineyeva A Hilenski L Lassegue B Griendling KK Harrison DG Dikalova AE. Nox2-induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension. Antioxid Redox Signal 2014;20:281-294
41. Dai DF Johnson SC Villarin JJ Chin MT Nieves-Cintron M Chen T Marcinek DJ Dorn GW Kang YJ Prolla TA Santana LF Rabinovitch PS. Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ Res 2011;108:837-846
42. Lacza Z Pankotai E BusijaDW. Mitochondrial nitric oxide synthase: Current concepts and controversies. Front Biosci (Landmark Ed) 2009;14:4436-4443
43. Hare JM. Nitroso-redox balance in the cardiovascular system. N Engl J Med 2004;351: 2112-2114
44. Chen CA Wang TY Varadharaj S Reyes LA Hemann C Talukder MAH Chen YR Druhan LJ Zweier JL. S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature 2010;468:1115-1118
45. Boulden BM Widder JD Allen JC Smith DA Al-Baldawi RN Harrison DG Dikalov SI Jo H Dudley J. Early determinants ofH2O2-induced endothelial dysfunction. Free Radic Biol Med 2006;41:810-817
46. Sartoretto JL Kalwa H PluthMDLippard SJ MichelT. Hydrogen peroxide differentially modulates cardiac myocyte nitric oxide synthesis. Proc Natl Acad Sci USA 2011;108: 15792-15797
47. Murdoch CE Brewer A Zhang M Vanhoutte D Heymans S Shah AM. Endothelialspecific overexpression of Nox2 enhances angiotensin ii-induced cardiac dysfunction and fibrosis. Circulation 2008;118:S314
48. Ray R Murdoch CE Wang M Santos CX Zhang M Alom-Ruiz S Anilkumar N Ouattara A Cave AC Walker SJ Grieve DJ Charles RL Eaton P Brewer AC Shah AM. Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo. Arterioscler Thromb Vasc Biol 2011;31:1368-1376
49. Craige SM Chen K Pei Y Li C Huang X Chen C Shibata R Sato KWalsh K Keaney JF. NADPHoxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation/clinical perspective. Circulation 2011;124:731-740
50. Schroder K Zhang M Benkhoff S Mieth A Pliquett R Kosowski J Kruse C Luedike P Michaelis URWeissmann N Dimmeler S Shah AM Brandes RP. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase/novelty and significance. Circ Res 2012;110:1217-1225
51. Landmesser U Dikalov S Price SR McCann L Fukai T Holland SM Mitch WE Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 2003;111:1201-1209
52. Moens AL Takimoto E Tocchetti CG Chakir K Bedja D Cormaci G Ketner EA Majmudar M Gabrielson K Halushka MK Mitchell JB Biswal S Channon KM Wolin MS Alp NJ Paolocci N Champion HC Kass DA. Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: Efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation 2008;117:2626-2636
53. Leucker TM Ge ZD Procknow J Liu Y Shi Y Bienengraeber M Warltier DC Kersten JR. Impairment of endothelial-myocardial interaction increases the susceptibility of cardiomyocytes to ischemia/reperfusion injury. PLoS One 2013;8:e70088
54. Meyer D Birchmeier C. Multiple essential functions of neuregulin in Development. Nature 1995;378:386-390
55. Gassmann M Casagranda F Orioli D SimonH Lai C Klein RLemke G. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 1995; 378:390-394
56. Lee KF Simon H Chen H Bates B Hung MC Hauser C. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 1995;378:394-398
57. ZhaoYY Sawyer DR Baliga RR Opel DJ Han X MarchionniMA Kelly RA. Neuregulins promote survival and growth of cardiac myocytes: Persistence of erbb2 and erbb4 expression in neonatal and adult ventricular myocytes. J Biol Chem 1998;273: 10261-10269.
58. Baliga RR Pimental DR Zhao YY Simmons WW Marchionni MA Sawyer DB Kelly RA. NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase p70S6K and MEK-MAPK-RSK. Am J Physiol Heart Circul Physiol 1999;277:H2026-H2037
59. Slamon DJ Leyland-Jones B Shak S Fuchs H Paton V Bajamonde A Fleming T Eiermann W Wolter J Pegram M Baselga J Norton L. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001;344:783-792
60. Rohrbach S Yan X Weinberg EO Hasan F Bartunek J Marchionni MA Lorell BH. Neuregulin in cardiac hypertrophy in rats with aortic stenosis: Differential expression of erbB2 and erbB4 receptors. Circulation 1999;100:407-412
61. Lemmens K Segers VFM Demolder MDeKeulenaerGW. Role of neuregulin-1/ErbB2 signaling in endothelium-cardiomyocyte cross-Talk. J Biol Chem 2006;281: 19469-19477
62. Crone SA Zhao YY Fan L Gu Y Minamisawa S Liu Y Peterson KL Chen J Kahn R Condorelli G Jr Chien KR Lee KF. ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat Med 2002;8:459-465
63. Garca-Rivello HN Taranda JN Said M Cabeza-Meckert P Vila-Petroff M Scaglione J Ghio S Chen J Lai C Laguens RP Lloyd KC Hertig CM. Dilated cardiomyopathy in Erb-b4-deficient ventricular muscle. Am J Physiol Heart Circ Physiol 2005;289: H1153-H1160
64. Liu FF Stone JR Schuldt AJT Okoshi K OkoshiMP Nakayama MHoKKL Manning WJ Marchionni MA Lorell BH Morgan JP Yan X. Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure. Am J Physiol Heart Circ Physiol 2005;289:H660-H666
65. Kuramochi Y Cote GM Guo X Lebrasseur NK Cui L Liao R Sawyer DB. Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1beta/erbB4 signaling. J Biol Chem 2004;279:51141-51147
66. Calderone A Thaik CM Takahashi N Chang DL Colucci WS. Nitric oxide atrial natriuretic peptide and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest 1998;101:812-818
67. Scherrer-Crosbie M Ullrich R Bloch KD NakajimaH Nasseri B AretzHT Lindsey ML VanconAC Huang PL LeeRT ZapolWMPicardMH.Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 2001; 104:1286-1291
68. Ruetten H Dimmeler S GehringD Ihling C Zeiher AM. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload. Cardiovasc Res 2005;66:444-453
69. Ichinose F Bloch KD Wu JC Hataishi R Aretz HT Picard MH Scherrer-Crosbie M. Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenitalNOS3 deficiency.AmJ Physiol Heart Circ Physiol 2004;286:H1070-H1075
70. Dawson D Lygate CA Zhang MH Hulbert K Neubauer S Casadei B. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation 2005;112:3729-3737
71. Fiedler B Lohmann SM Smolenski A Linnemuller S Pieske B Schroder F Molkentin JD Drexler H Wollert KC. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes. Proc Natl Acad Sci USA 2002;99:11363-11368
72. Heineke J Kempf T Kraft T Hilfiker A Morawietz H Scheubel RJ Caroni P Lohmann SM Drexler H Wollert KC. Downregulation of cytoskeletal muscle LIM protein by nitric oxide: Impact on cardiac myocyte hypertrophy. Circulation 2003; 107:1424-1432
73. Buys ES Raher MJ Blake SL Neilan TG Graveline AR Passeri JJ Llano M Perez-Sanz TM Ichinose F Janssens S Zapol WM Picard MH Bloch KD Scherrer-Crosbie M. Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload. Am J Physiol Heart Circ Physiol 2007;293:H620-H627
74. Loyer XGomezAM Milliez P Fernandez-Velasco M Vangheluwe P Vinet LCharue D Vaudin E ZhangW Sainte-Marie Y Robidel E Marty I Mayer B Jaisser F Mercadier JJ Richard S Shah AM Benitah JP Samuel JL Heymes C. Cardiomyocyte overexpression of neuronal nitric oxide synthase delays transition toward heart failure in response to pressure overload by preserving calcium cycling. Circulation 2008;117:3187-3198
75. Takimoto E Champion HC Li M Ren S Rodriguez ER Tavazzi B Lazzarino G Paolocci N Gabrielson KL Wang Y Kass DA. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest 2005;115:1221-1231
76. Tirziu D Chorianopoulos E Moodie KL Palac RT Zhuang ZW Tjwa M Roncal C Eriksson U Fu Q Elfenbein A Hall AE Carmeliet P Moons L Simons M. Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice. J Clin Invest 2007;117:3188-3197
77. Jaba IM Zhuang ZW Li N Jiang Y Martin KA Sinusas AJ Papademetris X Simons M SessaWCYoung LH Tirziu D.NOtriggersRGS4degradation to coordinate angiogenesis and cardiomyocyte growth. J Clin Invest 2013;123:1718-1731
78. DavydovIV Varshavsky A.RGS4is arginylated and degraded by the N-end rule pathway in vitro. J Biol Chem 2000;275:22931-22941
79. Lee MJ TasakiT Moroi K An JY Kimura S Davydov IVKwonYT.RGS4 and RGS5 are in vivo substrates of the N-end rule pathway. Proc Natl Acad Sci USA 2005;102: 15030-15035
80. Hu RG Sheng J Qi X Xu Z Takahashi TT Varshavsky A. The N-end rule pathway as a nitric oxide sensor controlling the levels of multiple regulators. Nature 2005;437: 981-986
81. Giordano FJ Gerber HP Williams SP VanBruggen N Bunting S Ruiz-Lozano P Gu Y Nath AK Huang Y Hickey R Dalton N Peterson KL Ross J Jr Chien KR Ferrara N. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci USA 2001;98:5780-5785
82. Shiojima I Sato K Izumiya Y Schiekofer S Ito M Liao R Colucci WSWalsh K. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 2005;115:2108-2118
83. Izumiya Y Shiojima I Sato K Sawyer DB Colucci WSWalsh K. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension 2006;47:887-893
84. Sano M Minamino T Toko H Miyauchi H Orimo M Qin Y Akazawa H Tateno K Kayama Y Harada M Shimizu I Asahara T Hamada H Tomita S Molkentin JD Zou Y Komuro I. p53-induced inhibition of Hif-1 causes cardiac dysfunction During pressure overload. Nature 2007;446:444-448
85. Semenza GL Prabhakar NR. HIF-1-dependent respiratory cardiovascular and redox responses to chronic intermittent hypoxia. Antioxid Redox Signal 2007;9:1391-1396
86. Gerald D Berra E Frapart YM Chan DA Giaccia AJ Mansuy D Pouyssugur J Yaniv M Mechta-Grigoriou F. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 2004;118:781-794
87. Matsushima S Kuroda J Ago T Zhai P Ikeda Y Oka S Fong GH Tian R Sadoshima J. Broad suppression of NADPH oxidase activity exacerbates ischemia/reperfusion injury through inadvertent downregulation of hypoxia-inducible factor-1aand upregulation of peroxisome proliferator-Activated receptor-A. Circ Res 2013;112:1135-1149
88. Kuroda J Ago T Matsushima S Zhai P Schneider MD Sadoshima J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci USA 2010;107:15565-15570
89. Fraisl P. Crosstalk between oxygen- And nitric oxide-dependent signaling pathways in angiogenesis. Exp Cell Res 2013;319:1331-1339
90. Lima B Lam GKW Xie L Diesen DL Villamizar N Nienaber J Messina E Bowles D Kontos CD Hare JM Stamler JS Rockman HA. Endogenous S-nitrosothiols protect against myocardial injury. Proc Natl Acad Sci USA 2009;106:6297-6302
91. Metzen E Zhou J JelkmannW Fandrey J BrÃne B. Nitric oxide impairs normoxic degradation of HIF-1α by inhibition of prolyl hydroxylases. Mol Biol Cell 2003;14: 3470-3481
92. Berchner-Pfannschmidt U Yamac H Trinidad B Fandrey J. Nitric oxide modulates oxygen sensing by hypoxia-inducible factor 1-dependent induction of prolyl hydroxylase 2. J Biol Chem 2007;282:1788-1796
93. Albig AR Schiemann WP. Identification and characterization of regulator of g protein signaling 4 (RGS4) as a novel inhibitor of tubulogenesis: RGS4 inhibits mitogenactivated protein kinases and vascular endothelial growth factor signaling. Mol Biol Cell 2005;16:609-625
94. Heineke J Auger-Messier M Xu J Oka T Sargent MA York A Klevitsky R Vaikunth S Duncan SA Aronow BJ Robbins J Crombleholm TM Molkentin JD. Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. J Clin Invest 2007;117:3198-3210
95. Oka T Xu J Molkentin JD. Re-employment of developmental transcription factors in adult heart disease. Sem Cell Dev Biol 2007;18:117-131
96. Hautala NTenhunen O Szokodi I Ruskoaho H. Direct left ventricular wall stretch activates GATA4 binding in perfused rat heart: Involvement of autocrine/paracrine pathways. Pflugers Arch 2002;443:362-369
97. Hautala N Tokola H LuodonpAA M Puhakka J Romppanen H Vuolteenaho O Ruskoaho H. Pressure overload increasesGATA4 binding activity via endothelin-1. Circulation 2001;103:730-735
98. Murray TV Smyrnias I Shah AM Brewer AC. NADPH oxidase 4 regulates cardiomyocyte differentiation via redox activation of c-Jun protein and the cis-regulation of GATA-4 gene transcription. J Biol Chem 2013;288:15745-15759
99. Bendall JK Cave AC Heymes C Gall N Shah AM. Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 2002;105:293-296
100. Johar S Cave AC Narayanapanicker A Grieve DJ Shah AM. Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. FASEB J 2006;20:1546-1548
101. Touyz RM Mercure C He Y Javeshghani D Yao G Callera GE Yogi A Lochard N Reudelhuber TL. Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase. Hypertension 2005; 45:530-537
102. Grieve DJ Byrne JA Siva A Layland J Johar S Cave AC Shah AM. Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform nox2 in cardiac contractile dysfunction occurring in response to pressure overload. J Am Coll Cardiol 2006; 47:817-826
103. Looi YH Grieve DJ Siva AWalker SJ Anilkumar N CaveAC Marber M Monaghan MJ Shah AM. Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension 2008;51:319-325
104. Doerries C Grote K Hilfiker-Kleiner D Luchtefeld M Schaefer A Holland SM Sorrentino S Manes C Schieffer B Drexler H Landmesser U. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction. Circ Res 2007;100:894-903
105. Satoh M Ogita H Takeshita KMukaiY Kwiatkowski DJ Liao JK. Requirement of Rac1 in the development of cardiac hypertrophy. Proc Natl Acad Sci USA 2006;103:7432-7437
106. Barcellos-Hoff MH Dix TA. Redox-mediated activation of latent transforming growth factor-beta 1. Mol Endocrinol 1996;10:1077-1083
107. Park SK Kim JSeomunY Choi J KimDH HanIO Lee EH Chung SK Joo CK. Hydrogen peroxide is a novel inducer of connective tissue growth factor. Biochem Biophys Res Commun 2001;284:966-971
108. Koitabashi N Danner T Zaiman AL Pinto YM Rowell J Mankowski J Zhang D Nakamura T Takimoto E Kass DA. Pivotal role of cardiomyocyte TGF-b signaling in the murine pathological response to sustained pressure overload. J Clin Invest 2011; 121:2301-2312
109. Cucoranu I Clempus R Dikalova A Phelan PJ Ariyan S Dikalov S Sorescu D. NAD(P)H oxidase 4 mediates transforming growth factor-{beta}1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 2005;97:900-907
110. Spinale FG Zile MR. Integrating the myocardial matrix into heart failure recognition and management. Circ Res 2013;113:725-738
111. Spinale FG. Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function. Physiol Rev 2007;87:1285-1342
112. Wang W Sawicki G Schulz R. Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc Res 2002;53:165-174
113. He BJ Joiner Ml Singh MV Luczak ED Swaminathan PD Koval OM Kutschke W Allamargot C Yang J Guan X Zimmerman K Grumbach IM Weiss RM Spitz DR Sigmund CD Blankesteijn WM Heymans S Mohler PJ Anderson ME. Oxidation of CaMKII determines the cardiotoxic effects of aldosterone. Nat Med 2011;17: 1610-1618
114. Frey RS Ushio-Fukai M Malik AB. NADPH oxidase-dependent signaling in endothelial cells: Role in physiology and pathophysiology. Antioxid Redox Signal 2009;11:791-810
115. Frey RSRahman A Kefer JC Minshall RD Malik AB. PKCzeta regulatesTNF-A-induced activation of NADPH oxidase in endothelial cells. Circ Res 2002;90:1012-1019
116. Li JM Fan LM Christie MR Shah AM. Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: Role of p47phox phosphorylation and binding to TRAF4. Mol Cell Biol 2005;25:2320-2330
117. Goette A Bukowska A Lendeckel U Erxleben M Hammwohner M Strugala D Pfeiffenberger J Rohl FW Huth C Ebert MPA Klein HU Rocken C. Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression. Circulation 2008;117:732-742
118. Matheny HE Deem TL Cook-Mills JM. Lymphocyte migration through monolayers of endothelial cell lines involves VCAM-1 signaling via endothelial cell NADPH oxidase. J Immunol 2000;164:6550-6559
119. Eisenberg LM Markwald RR. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res 1995;77:1-6
120. von Gise A PuWT. Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease. Circ Res 2012;110:1628-1645
121. Zeisberg EM Tarnavski O Zeisberg M Dorfman AL McMullen JR Gustafsson E Chandraker A Yuan X Pu WT Roberts AB Neilson EG Sayegh MH Izumo S Kalluri R. Endothelial-To-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007;13:952-961
122. Widyantoro B Emoto N Nakayama K Anggrahini DW Adiarto S Iwasa N Yagi K Miyagawa K Rikitake Y Suzuki T Kisanuki YY YanagisawaM Hirata KI. Endothelial cellderived endothelin-1 promotes cardiac fibrosis in Diabetic hearts through stimulation of endothelial-To-mesenchymal transition. Circulation 2010;121:2407-2418
123. Farre ALP Casado S. Heart failure redox alterations and endothelial dysfunction. Hypertension 2001;38:1400-1405
124. Kubo SH Rector TS Bank AJ Williams RE Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991;84:1589-1596
125. Ontkean M Gay R Greenberg B. Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure. Circ Res 1991;69:1088-1096
126. Akiyama E Sugiyama S Matsuzawa Y Konishi M Suzuki H Nozaki T Ohba K Matsubara J Maeda H Horibata Y Sakamoto K Sugamura K Yamamuro M Sumida H Kaikita K Iwashita S Matsui K Kimura K Umemura S Ogawa H. Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction. J Am Coll Cardiol 2012;60: 1778-1786
127. van Heerebeek L Borbely A Niessen HWM Bronzwaer JGF van Der Velden J Stienen GJM Linke WA Laarman GJ Paulus WJ. Myocardial structure and function Differ in systolic and diastolic heart failure. Circulation 2006;113:1966-1973
128. Westermann D Lindner D Kasner M Zietsch C Savvatis K Escher F von Schlippenbach J Skurk C Steendijk P Riad A Poller W Schultheiss HP Tschope C. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ 2011;4:44-52
129. Kasner M Westermann D Lopez BA Gaub R Escher F Kuhl U Schultheiss HP Tschope C. Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction. J Am Coll Cardiol 2011;57:977-985
130. Selby DE Palmer BM LeWinterMM Meyer M. Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction. J Am Coll Cardiol 2011;58:147-154
131. van Heerebeek L Hamdani N Falcao-Pires IS Leite-Moreira AF Begieneman MPV Bronzwaer JGF van Der Velden J Stienen GJM Laarman GJ Somsen A Verheugt FWA Niessen HWM Paulus WJ. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation 2012;126:830-839
132. Paulus WJ Tschope C. A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 2013;62:263-271
133. Bauersachs J Widder JD. Endothelial dysfunction in heart failure. Pharmacol Rep 2008; 60:119-126
134. Grocott-Mason R Anning P Evans H Lewis MJ Shah AM. Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am J Physiol Heart Circ Physiol 1994;267:H1804-H1813
135. Anning PB Grocott-Mason RM Lewis MJ Shah AM. Enhancement of left ventricular relaxation in the isolated heart by an angiotensin-converting enzyme inhibitor. Circulation 1995;92:2660-2665
136. Borbely A Falcao-Pires I van Heerebeek L Hamdani N Edes IN Gavina C Leite-Moreira AF Bronzwaer JGF Papp ZN van Der Velden J Stienen GJM Paulus WJ. Hypophosphorylation of the stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ Res 2009;104:780-786
137. Kruger M Kotter S Grutzner A Lang P Andresen C Redfield MM Butt E dos Remedios CG LinkeWA. Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circ Res 2009;104:87-94
138. Bishu K Hamdani N Mohammed SF Kruger M Ohtani T Ogut O Brozovich FV Burnett JC LinkeWA Redfield MM. Sildenafil and B-Type natriuretic peptide acutely phosphorylate titin and improve diastolic distensibility in vivo. Circulation 2011;124: 2882-2891
139. MacCarthy PA Shah AM. Impaired endothelium-dependent regulation of ventricular relaxation in pressure-overload cardiac hypertrophy. Circulation 2000;101:1854-1860
140. MacCarthy PA Grieve DJ Li JM Dunster C Kelly FJ Shah AM. Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: Role of reactive oxygen species and NADPH oxidase. Circulation 2001;104:2967-2974
141. Trochu JN Bouhour JB Kaley G Hintze TH. Role of endothelium-derived nitric oxide in the regulation of cardiac oxygen metabolism: Implications in health and disease. Circ Res 2000;87:1108-1117
142. Brown GC Borutaite V. Nitric oxide and mitochondrial respiration in the heart. Cardiovasc Res 2007;75:283-290
143. Silberman GA Fan TH Liu H Jiao Z Xiao HD Lovelock JD Boulden BM Widder J Fredd S Bernstein KE Wolska BM Dikalov S Harrison DG Dudley SC. Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction. Circulation 2010;121: 519-528